• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜碱性粒细胞反应与变应原免疫治疗中的耐受诱导:一项长期蜇伤挑战研究。

Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.

机构信息

University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.

出版信息

Allergy. 2012 Jun;67(6):822-30. doi: 10.1111/j.1398-9995.2012.02817.x. Epub 2012 Apr 3.

DOI:10.1111/j.1398-9995.2012.02817.x
PMID:22469017
Abstract

BACKGROUND

There is no in vitro test to predict the induction of long-term tolerance in patients treated with venom immunotherapy (VIT). The aim of this study was to investigate whether immunotherapy-induced changes in basophil responsiveness reflect a state of protection and the induction of a tolerance.

METHODS

Twenty-three patients with allergic reaction after Hymenoptera sting (11 wasp and 12 honeybee) were treated with VIT. In all patients, a CD63 basophil activation test was performed before the beginning of immunotherapy, after 1 year and after completing 4-6.5 years of immunotherapy (approximately 1 year after stopping). The tolerance was then evaluated by a sting challenge test. The basophil activation test was repeated 3-6 months after the challenge.

RESULTS

Twenty-two subjects showed a negative sting challenge, and one subject, a positive sting challenge. Allergen-specific basophil response remained unchanged after 1 year of immunotherapy. However, after immunotherapy, a significant and approximately fourfold decrease was demonstrated in all tolerant subjects mainly in response to submaximal 0.1 μg/ml allergen concentration. This depression was sustained and did not change with the sting challenge test. In a nontolerant patient with a positive sting challenge, basophil response did not change.

CONCLUSIONS

Our results suggest that the depression of allergen-specific basophil response seems to be associated with the induction of a tolerance after completing a course of VIT.

摘要

背景

目前尚无体外检测方法可预测接受毒液免疫治疗(VIT)的患者产生长期耐受的情况。本研究旨在探讨免疫治疗诱导的嗜碱性粒细胞反应变化是否反映了一种保护状态和诱导耐受的情况。

方法

23 例因被蜂蜇(11 例黄蜂,12 例蜜蜂)而出现过敏反应的患者接受了 VIT 治疗。在所有患者中,在开始免疫治疗之前、治疗 1 年以及完成 4-6.5 年免疫治疗(大约在停止治疗 1 年后)时进行 CD63 嗜碱性粒细胞激活试验。然后通过蜇伤挑战试验评估耐受情况。在挑战后 3-6 个月重复进行嗜碱性粒细胞激活试验。

结果

22 名患者蜇伤挑战呈阴性,1 名患者蜇伤挑战呈阳性。在免疫治疗 1 年后,过敏原特异性嗜碱性粒细胞反应保持不变。然而,在免疫治疗后,所有耐受患者的反应(主要是对亚最大浓度 0.1μg/ml 过敏原)均显著且大约四倍下降。这种抑制持续存在,并且不因蜇伤挑战试验而改变。在蜇伤挑战阳性、无耐受的患者中,嗜碱性粒细胞反应没有变化。

结论

我们的结果表明,过敏原特异性嗜碱性粒细胞反应的抑制似乎与完成 VIT 疗程后诱导耐受有关。

相似文献

1
Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.嗜碱性粒细胞反应与变应原免疫治疗中的耐受诱导:一项长期蜇伤挑战研究。
Allergy. 2012 Jun;67(6):822-30. doi: 10.1111/j.1398-9995.2012.02817.x. Epub 2012 Apr 3.
2
Basophil sensitivity in patients not responding to venom immunotherapy.对毒液免疫疗法无反应患者的嗜碱性粒细胞敏感性。
Int Arch Allergy Immunol. 2008;146(3):248-54. doi: 10.1159/000116361. Epub 2008 Feb 13.
3
The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.黄蜂毒液过敏中的嗜碱性粒细胞激活试验:敏感性、特异性及监测特异性免疫疗法
Allergy. 2004 Oct;59(10):1102-9. doi: 10.1111/j.1398-9995.2004.00624.x.
4
Expression of activation markers on basophils in a controlled model of anaphylaxis.在过敏反应的可控模型中嗜碱性粒细胞上活化标志物的表达
J Allergy Clin Immunol. 2007 May;119(5):1181-8. doi: 10.1016/j.jaci.2007.01.008. Epub 2007 Mar 1.
5
Monitoring honeybee venom immunotherapy in children with the basophil activation test.采用嗜碱性粒细胞活化试验监测儿童蜂毒免疫治疗。
Pediatr Allergy Immunol. 2012 Mar;23(2):166-72. doi: 10.1111/j.1399-3038.2011.01233.x. Epub 2011 Dec 4.
6
Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.嗜碱性粒细胞活化可预测变应原免疫治疗后患者的临床敏感性。
J Investig Allergol Clin Immunol. 2010;20(2):110-6.
7
The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study.膜翅目毒液过敏中CD63嗜碱性粒细胞活化试验:一项前瞻性研究。
Allergy. 2004 Oct;59(10):1110-7. doi: 10.1111/j.1398-9995.2004.00400.x.
8
Use of CD63 expression as marker of in vitro basophil activation in identifying the culprit in insect venom allergy.使用CD63表达作为体外嗜碱性粒细胞活化的标志物来鉴定昆虫毒液过敏的罪魁祸首。
J Investig Allergol Clin Immunol. 2004;14(1):10-6.
9
Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.在接受常规膜翅目毒液免疫治疗时仍对叮咬激发试验有反应的患者,通过增加毒液剂量得到保护。
J Allergy Clin Immunol. 2001 Dec;108(6):1027-32. doi: 10.1067/mai.2001.119154.
10
Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.流动辅助定量体外活化嗜碱性粒细胞在黄蜂毒液过敏诊断及黄蜂毒液免疫治疗随访中的应用
Cytometry B Clin Cytom. 2007 May;72(3):196-203. doi: 10.1002/cyto.b.20142.

引用本文的文献

1
The usefulness of the basophil activation test for monitoring the effectiveness of wasp venom immunotherapy in different age groups.嗜碱性粒细胞活化试验在监测不同年龄组黄蜂毒液免疫疗法有效性方面的作用。
Clin Transl Allergy. 2025 Aug;15(8):e70073. doi: 10.1002/clt2.70073.
2
StingReady: A Novel Device for Controlled Insect Sting Challenge-From Field Capture to Clinical Application.StingReady:一种用于可控昆虫叮咬激发试验的新型装置——从野外捕获到临床应用
Toxins (Basel). 2025 May 22;17(6):260. doi: 10.3390/toxins17060260.
3
Epitope-Specific Antibodies in Allergic Disease and Clinical Tolerance.
过敏性疾病与临床耐受性中的表位特异性抗体
Immunol Rev. 2025 Jul;332(1):e70042. doi: 10.1111/imr.70042.
4
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper.嗜碱性粒细胞活化试验:在过敏肿瘤学中为诊断、治疗和预后应用搭建过敏与肿瘤学之间的桥梁:一篇欧洲变态反应和临床免疫学会立场文件
Allergy. 2025 Aug;80(8):2097-2112. doi: 10.1111/all.16607. Epub 2025 Jun 12.
5
Cellular and Humoral Response After Induction of Protection and After Finishing Venom Immunotherapy.诱导产生保护作用后及完成毒液免疫治疗后的细胞和体液反应。
Biomolecules. 2024 Nov 24;14(12):1494. doi: 10.3390/biom14121494.
6
Basophil activation test in Hymenoptera venom allergy.膜翅目毒液过敏中的嗜碱性粒细胞活化试验
Allergol Select. 2024 Aug 19;8:293-298. doi: 10.5414/ALX02522E. eCollection 2024.
7
Blood Transcriptomics Identifies Multiple Gene Expression Pathways Associated with the Clinical Efficacy of Venom Immunotherapy.血液转录组学鉴定出与毒液免疫治疗临床疗效相关的多个基因表达途径。
Int J Mol Sci. 2024 Mar 20;25(6):3499. doi: 10.3390/ijms25063499.
8
Advocacy of Precision Allergy Molecular Diagnosis in Decision Making for the Eligibility of Customized Allergen Immunotherapy.在定制过敏原免疫疗法适用性决策中倡导精准过敏分子诊断
Curr Issues Mol Biol. 2023 Dec 12;45(12):9976-9984. doi: 10.3390/cimb45120623.
9
Natural and Induced Tolerance to Hymenoptera Venom: A Single Mechanism?自然和诱导对膜翅目毒液的耐受性:单一机制?
Toxins (Basel). 2022 Jun 22;14(7):426. doi: 10.3390/toxins14070426.
10
Venom Immunotherapy: Immune Mechanisms of Induced Protection and Tolerance.毒液免疫治疗:诱导保护和耐受的免疫机制。
Cells. 2021 Jun 22;10(7):1575. doi: 10.3390/cells10071575.